Science and Technology Science and Technology
Fri, January 17, 2025
[ 05:02 PM ] - Nature
Trump's science advisers: how they could influence his second presidency
[ 04:22 PM ] - MSN
As bird flu concerns grow, scientists race to develop new vaccines
[ 02:22 PM ] - Forbes
How Genomics Uses DNA And Tech To Make Healthcare Accessible To All
[ 01:22 PM ] - MSN
Multiyear droughts are worsening. Here's where they have the most impacts.
[ 01:22 PM ] - MSN
Southeast Polk High School teacher receives Presidential Award
[ 01:22 PM ] - MSN
Step inside MOSI's transformed digital dome theatre
[ 01:02 PM ] - MSN
Ludhiana: Students showcase innovative ideas at science expo
[ 12:42 PM ] - MSN
Key enzyme identified as potential target for cancer immunotherapy
[ 12:42 PM ] - MSN
Wilmington Tech Firm To Receive $105 Million Federal Investment
[ 11:22 AM ] - MSN
DepEd, DOST sign MOU to boost STEM curriculum
[ 11:22 AM ] - Forbes
Warning Signs That AI Foundational Research And A .. lent Could Be Slipping Through Academia's Fingers
[ 10:02 AM ] - Forbes
Financial Sharing Models For An AI World
[ 10:02 AM ] - MSN
Germany unleashes AMD-powered Hunter supercomputer
[ 10:02 AM ] - businessday
Top 5 countries that are best for STEM courses
[ 06:22 AM ] - Forbes
The Year Ahead: Promise For Quantum Growth
[ 04:42 AM ] - MSN
Sutherland community protests government's violation of land use act
[ 04:02 AM ] - Wired
Harnessing AI and data science to discover life-changing medicines at AstraZeneca
[ 03:22 AM ] - MSN
Superhuman hearing: That's what this Hyd boy is enabling
[ 01:22 AM ] - MSN
Kerala SET January Admit Card 2025 out at lbsedp.lbscentre.in, download link here
[ 01:02 AM ] - MSN
Taiwan biz delegation eyes ecozone development in PH
[ 01:02 AM ] - MSN
The Science Behind Renewable Energy Efficiency
Thu, January 16, 2025
[ 11:42 PM ] - MSN
Scientists take major step forward on quest to cr .. tic fuel cells: 'Outstanding initial performance'
[ 11:22 PM ] - MSN
Study shows seed impact mills clobber waterhemp seed viability
[ 10:22 PM ] - MSN
5 ways to close the gap for Black women in STEM
[ 07:42 PM ] - MSN
SpaceX loses spacecraft after catching rocket booster at the launch pad in latest Starship test
[ 07:02 PM ] - collider
10 Essential Sci-Fi Movies of the 1990s, Ranked
[ 06:22 PM ] - MSN
Scientists say they are close to resurrecting a lost species. Is the age of de-extinction upon us?
[ 06:02 PM ] - MSN
SpaceX's Starship mega rocket blasts off on its most complex test flight yet
[ 05:42 PM ] - MSN
Art analysis: 2D multifractal tools examine Jackson Pollock's expressionism
[ 04:42 PM ] - MSN
New quantum clock uses entanglement to push science beyond existing limits

Key enzyme identified as potential target for cancer immunotherapy


Published on 2025-01-17 12:42:25 - MSN
  Print publication without navigation

  • Scientists from A*STAR Genome Institute of Singapore (A*STAR GIS) have uncovered that a key enzyme
  • P4HA1 prolyl hydroxylase, is strongly induced in CD8+ T cells in solid cancer, the primary immune cells involved in combating cancer.

The article from MSN discusses a significant advancement in cancer research where scientists have identified a key enzyme, TAK1, as a potential target for cancer immunotherapy. This enzyme plays a crucial role in regulating the immune response within the tumor microenvironment. Researchers found that by inhibiting TAK1, they could enhance the effectiveness of immune checkpoint inhibitors, which are drugs designed to help the immune system recognize and attack cancer cells. This discovery could lead to new therapeutic strategies that improve the outcomes of immunotherapy for patients with various types of cancer, potentially overcoming resistance to current treatments and providing a more personalized approach to cancer therapy.

Read the Full MSN Article at:
[ https://www.msn.com/en-us/science/biochemistry/key-enzyme-identified-as-potential-target-for-cancer-immunotherapy/ar-AA1xnWMj ]
Contributing Sources